Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells.
The misfolding and aggregation of normally soluble proteins has emerged as a key feature of several neurodegenerative diseases. In Parkinson's disease, progressive loss of dopaminergic neurons is accompanied by polymerization of the cytoplasmic protein alpha-synuclein (alphaS) into filamentous inclusions found in neuronal somata (Lewy bodies) and dendrites (Lewy neurites). Similar alphaS aggregates occur in cortical neurons in dementia with Lewy bodies. Numerous reports now indicate that alphaS can interact with lipids. We previously found that treating dopaminergic cells expressing alphaS with polyunsaturated fatty acids (PUFAs) induced the formation of soluble, sodium dodecyl sulfate-stable oligomers whereas treatment with saturated fatty acids did not. Here, we examine the relevance of alphaS-PUFA interactions to the development of Parkinson's disease-like cytopathology. Exposure of alphaS-overexpressing dopaminergic or neuronal cell lines to physiological levels of a PUFA induced the formation of proteinaceous inclusions in the cytoplasm. Kinetic experiments indicated that PUFA-induced soluble oligomers of alphaS precede these Lewy-like inclusions. Importantly, we found that alphaS oligomers were associated with cyto-toxicity, whereas the development of Lewy-like inclusions appeared to be protective. We conclude that alterations in PUFA levels can lead to aggregation of alphaS and subsequent deposition into potentially cyto-toxic oligomers that precede inclusions in dopaminergic cells.
Assayag
Karen
K
Department of Cellular Biochemistry and Human Genetics, Hebrew University, Hadassah Medical School, Jerusalem, Israel.
Yakunin
Evgenia
E
Loeb
Virginie
V
Selkoe
Dennis J
DJ
Sharon
Ronit
R
D002460:Cell Line; D002470:Cell Survival; D005231:Fatty Acids, Unsaturated / Q000378:metabolism / Q000633:toxicity*; D018840:HSP70 Heat-Shock Proteins / Q000032:analysis / Q000378:metabolism; D006801:Humans; D016631:Lewy Bodies / Q000737:chemistry / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D010300:Parkinson Disease / Q000378:metabolism* / Q000473:pathology; D010766:Phosphorylation; D025801:Ubiquitin / Q000032:analysis / Q000378:metabolism; D051844:alpha-Synuclein / Q000032:analysis / Q000378:metabolism*
D005231:Fatty Acids, Unsaturated; D018840:HSP70 Heat-Shock Proteins; D025801:Ubiquitin; D051844:alpha-Synuclein